sepsi
major
caus
morbid
mortal
high
incom
well
middl
low
incom
countri
million
case
sepsi
estim
occur
year
around
world
account
death
europ
unit
state
recent
studi
differ
countri
show
incid
sepsi
well
number
sepsisrel
death
continu
increas
present
blood
cultur
consid
gold
standard
aetiolog
diagnosi
sepsi
although
blood
cultur
associ
high
specif
speci
identif
limit
substanti
time
delay
low
sensit
especi
slowgrow
fastidi
organ
effort
address
limit
blood
cultur
nucleic
acid
amplif
test
naat
develop
improv
sensit
decreas
time
identif
microorgan
caus
bacteraemia
sever
commerci
multiplex
assay
base
differ
techniqu
convent
polymeras
chain
reaction
pcr
analytik
gena
germani
realtim
pcr
sepsi
realtim
test
seegen
korea
septifast
roch
switzerland
molzym
germani
microarray
sepsi
mobidiag
finland
market
assay
test
sever
studi
rare
clinic
valid
result
aim
populationbas
studi
therefor
evalu
clinic
util
two
commerci
naat
sepsi
realtim
test
sepsi
patient
suspect
sepsi
sepsi
realtim
test
pcrbase
test
screen
speci
gram
posit
bacteria
twelv
speci
gram
neg
six
speci
fungi
three
resist
gene
meca
vana
vanb
directli
whole
blood
sampl
microarraybas
assay
call
sepsi
combin
genom
amplif
convent
pcr
microarray
technolog
simultan
identif
bacteri
pathogen
fungal
pathogen
three
resist
gene
meca
vana
vanb
posit
blood
cultur
septemb
june
prospect
observ
studi
incid
communityonset
sever
sepsi
septic
shock
adult
conduct
skaraborg
hospit
western
region
sweden
limit
period
prospect
studi
februari
april
naat
perform
part
routin
patient
care
addit
blood
cultur
patient
year
admit
emerg
depart
suspicion
communityonset
sepsi
patient
receiv
oral
written
inform
studi
patient
suspect
sepsi
sever
sepsi
mandatori
rapidli
make
appropri
sampl
microbiolog
diagnosi
antibiot
treatment
institut
microbiolog
test
use
appropri
approv
test
need
patient
consent
accord
swedish
law
diagnost
test
made
upon
arriv
emerg
depart
addit
sampl
made
patient
sick
andor
die
within
hour
could
never
give
inform
consent
patient
could
give
inform
consent
evalu
anonym
diagnosi
result
commerci
avail
test
use
diagnost
purpos
suspect
sepsi
region
ethic
committe
gothenburg
approv
studi
consent
process
studi
episod
defin
separ
case
clinic
suspect
communityonset
sepsi
treat
intraven
antibiot
one
episod
per
patient
admiss
includ
final
data
analysi
avoid
bia
episod
two
set
blood
cultur
two
differ
punctur
site
collect
administr
first
dose
intraven
antibiot
howev
episod
due
feasibl
one
set
blood
cultur
collect
blood
cultur
conduct
fn
franc
type
definit
speci
identif
malditof
ms
perform
microflex
lt
mass
spectromet
bruker
dalton
unit
state
biotyp
softwar
use
default
paramet
set
spectral
score
use
cutoff
correct
identif
antibiot
suscept
determin
accredit
laboratori
method
accord
eucast
guidelin
wwweucastorg
test
procedur
perform
ml
fresh
whole
blood
edta
collect
administr
antibiot
older
hour
dna
extract
whole
blood
perform
use
selectna
blood
pathogen
kit
molzym
germani
first
step
extract
lysi
human
cell
digest
human
dna
manual
perform
accord
manufactur
instruct
pure
bacterialfung
dna
extract
automat
prelys
sampl
instrument
nordiag
arrowliaison
ixt
diasorin
itali
first
pcr
produc
amplicon
bank
perform
use
kit
magicplex
sepsi
amplif
geneamp
pcr
system
appli
biosystem
unit
state
realtim
pcr
perform
magicplex
screen
realtim
detect
kit
biorad
unit
state
screen
reveal
presenc
gram
posit
gram
neg
bacteria
drug
resist
gene
fungi
speci
identif
perform
magicplex
id
realtim
detect
kit
sampl
becam
posit
screen
step
pcrreaction
set
uvbox
accord
recommend
manufactur
dedic
softwar
seegen
viewer
use
interpret
analysi
data
result
everi
sampl
present
tabl
detect
detect
whole
process
control
includ
assay
valid
assay
result
could
interpret
perform
aliquot
deriv
blood
cultur
bottl
remov
autom
blood
cultur
system
remov
bottl
store
day
dna
extract
perform
episod
aliquot
taken
pair
blood
cultur
bottl
one
aerob
one
anaerob
bottl
deriv
first
punctur
site
volum
withdrawn
bottl
regardless
blood
cultur
bottl
found
posit
neg
sampl
volum
pair
bottl
pool
togeth
prior
dna
extract
dna
extract
use
sampl
volum
elut
final
volum
use
magna
pure
nucleic
acid
isol
kit
magnapur
compact
system
roch
appli
scienc
switzerland
procedur
microarray
assay
perform
accord
protocol
provid
manufactur
briefli
bacteri
fungal
pcr
master
mix
prepar
pcr
reaction
set
laminar
airflow
bench
amplifi
pcr
product
handl
pcr
amplif
bacteri
pcr
product
fungal
pcr
product
deriv
episod
ad
well
microarray
subsequ
hybrid
stain
procedur
perform
detect
analysi
sampl
dedic
softwar
advisor
use
base
outcom
sever
builtin
control
softwar
evalu
whether
perform
assay
accept
analysi
paramet
adjust
automat
without
manual
involv
record
patient
microbi
find
assess
two
senior
physician
infecti
diseas
gj
clinic
judgment
base
patient
histori
special
refer
sudden
onset
fever
rigor
gastrointestin
symptom
tachypnea
mental
confus
pain
proport
muscl
weak
physic
examin
done
attent
blood
pressur
mm
hg
respiratori
rate
oxygen
satur
standard
biomark
includ
serum
lactat
leucocyt
cell
count
neutrophillymphocyt
count
ratio
creactiv
protein
judgment
also
base
imag
microbiolog
test
suspect
infecti
foci
includ
cultur
pcr
antigen
test
apart
naat
assay
describ
detail
remain
challeng
determin
aetiolog
signific
organ
detect
blood
appli
especi
naat
also
convent
blood
cultur
although
lesser
degre
studi
decis
aetiolog
signific
detect
organ
made
base
expect
pathogen
tabl
clinic
present
previous
describ
detect
organ
interpret
clinic
relev
unknown
signific
contamin
accord
algorithm
describ
figur
organ
detect
naat
also
regard
clinic
relev
stringent
criteria
posit
blood
cultur
result
microorgan
unknown
aetiolog
signific
find
consid
consist
clinic
diagnosi
implic
medic
manag
patient
howev
link
microorgan
medic
condit
patient
exclud
mcnemar
test
conduct
compar
proport
pair
sampl
wherea
z
test
perform
compar
proport
independ
sampl
twosid
p
valu
consid
statist
signific
concord
blood
cultur
naat
test
kappa
statist
interrat
agreement
cutoff
valu
kappa
valu
describ
elsewher
consid
moder
agreement
good
agreement
statist
analys
perform
use
matlab
v
mathwork
inc
unit
state
rate
episod
posit
multiplex
pcr
wherea
rate
episod
posit
blood
cultur
p
cohen
kappa
coeffici
agreement
result
multiplex
pcr
blood
cultur
ci
total
clinic
relev
find
episod
find
unknown
signific
episod
detect
multiplex
pcr
blood
cultur
find
episod
clinic
relev
one
find
unknown
signific
multiplex
pcr
blood
cultur
result
agre
clinic
relev
find
figur
multiplex
pcr
miss
clinic
relev
find
episod
one
find
unknown
signific
hand
find
identifi
multiplex
pcr
episod
detect
blood
cultur
fifteen
find
consid
clinic
relev
five
find
consid
proven
aetiolog
infect
sinc
bacteria
found
cultur
site
infect
tabl
remain
ten
find
made
multiplex
pcr
neg
blood
cultur
diagnost
test
consist
clinic
diagnosi
therefor
regard
clinic
relev
tabl
twentythre
find
detect
multiplex
pcr
blood
cultur
regard
unknown
signific
ten
find
gram
posit
bacteria
eleven
find
gram
neg
bacteria
two
find
candida
speci
tabl
rate
episod
posit
microarray
assay
blood
cultur
p
cohen
kappa
statist
agreement
result
microarray
blood
cultur
ci
total
clinic
relev
find
episod
five
find
unknown
signific
five
episod
detect
microarray
result
microarray
blood
cultur
show
concord
clinic
relev
find
figur
microarray
fail
detect
four
clinic
relev
find
detect
blood
cultur
howev
two
find
belong
speci
cover
microarray
panel
streptococcu
anginosu
streptococcu
group
g
microarray
identifi
one
clinic
relev
find
five
find
unknown
signific
detect
either
blood
cultur
multiplex
pcr
tabl
focu
studi
clinic
util
two
commerci
naat
aetiolog
diagnosi
patient
suspect
sepsi
found
multiplex
pcr
assay
ad
diagnost
valu
time
detect
clinic
relev
microb
miss
blood
cultur
result
microarraybas
assay
correspond
well
blood
cultur
clinic
util
reduc
prerequisit
timeconsum
cultiv
current
blood
cultur
consid
gold
standard
aetiolog
diagnosi
sepsi
although
suffer
low
sensit
detect
viabl
microorgan
medium
optim
cultur
fungi
fastidi
bacteria
thu
blood
cultur
consid
poor
gold
standard
impli
difficulti
evalu
novel
sepsi
test
sinc
laboratori
refer
standard
sepsi
diagnosi
exist
reason
differ
refer
standard
use
studi
assess
sepsi
test
use
blood
cultur
result
alon
gold
standard
wherea
other
consid
pathogen
find
detect
method
assess
perform
blood
cultur
two
naat
classifi
find
judg
clinic
relev
true
posit
diagnost
sensit
multiplex
pcr
tabl
compar
rate
similar
studi
carrara
et
al
p
well
specif
vs
p
howev
loonen
et
al
report
significantli
lower
sensit
p
specif
p
microarray
assay
observ
significantli
lower
diagnost
sensit
vs
p
tabl
wherea
specif
equal
vs
p
compar
previou
studi
use
differ
gold
standard
studi
popul
may
explain
observ
differ
perform
characterist
although
multiplex
pcr
assay
could
detect
clinic
relev
microb
offer
ad
diagnost
valu
detect
sever
import
pathogen
detect
convent
culturebas
method
tabl
consequ
concord
result
blood
cultur
multiplex
pcr
assay
moder
kappa
tabl
wherea
microarray
result
show
high
degre
agreement
result
blood
cultur
kappa
tabl
result
could
expect
sinc
microarray
assay
perform
aliquot
deriv
blood
cultur
bottl
wherea
multiplex
pcr
perform
microbi
dna
extract
differ
whole
blood
sampl
cultur
portion
remark
find
multiplex
pcr
ml
whole
blood
reach
sensit
compar
cultur
use
ml
blood
despit
stringent
criteria
clinic
relev
pcr
case
howev
method
fail
detect
number
sepsi
case
strictli
quantit
aspect
detect
level
microorgan
blood
sampl
given
time
diagnost
sensit
depend
concentr
microorgan
volum
sampl
extent
variat
yield
bacteria
time
known
bacteraemia
averag
concentr
cfuml
blood
report
arpi
et
al
jonsson
et
al
theoret
calcul
probabl
detect
bacteria
function
concentr
blood
found
empir
blood
cultur
case
escherichia
coli
aureu
bacteraemia
probabl
concentr
cfuml
gain
yield
microorgan
increas
volum
cultur
blood
modern
autom
cultur
system
emphas
cockerhil
et
al
lee
et
al
obtain
sensit
system
four
blood
cultur
involv
ml
need
gain
probabl
due
detect
minut
concentr
either
enhanc
cultur
system
overcom
effect
earli
antibiot
therapi
resin
naat
introduc
diagnos
sepsi
sampl
blood
may
add
new
inform
impli
higher
analyt
sensit
definit
analyt
sensit
assay
refer
smallest
valu
analyt
resolv
given
degre
confid
synonym
diagnost
sensit
singl
bacteri
cell
obvious
smallest
theoret
unit
appli
blood
cultur
cultur
wider
sens
naat
singl
bacteri
cell
dead
aliv
may
contain
multipl
certain
target
sequenc
eg
bacteria
conserv
rrna
gene
sequenc
often
use
pcr
templat
due
high
copi
number
cell
downsid
use
detect
method
high
analyt
sensit
pcr
increas
number
find
unknown
signific
well
contamin
cope
unexpect
microbi
find
necessarili
corrobor
clinic
pictur
transloc
bacteria
fungi
mucos
gut
barrier
patient
malign
parenter
nutrit
increas
diagnost
dilemma
thu
urg
tighten
commun
laboratori
clinician
organis
assembl
critic
review
unexpect
find
also
qualit
aspect
certain
speci
seem
correl
better
genuin
sepsi
other
ie
enterobacteriacea
spp
pneumococci
detect
ident
microorgan
multipl
sampl
site
occas
anoth
genuin
marker
true
bacteraemia
impli
singl
find
microb
one
detect
system
eg
cultur
may
move
interpret
probabl
proven
find
done
eg
pcr
howev
true
bacteraemia
also
occur
patient
void
inflammatori
respons
shall
regard
benign
find
follow
factor
rule
first
transloc
bacteria
gut
bloodstream
may
occur
patient
malfunct
mucos
barrier
well
known
exampl
e
cloaca
occult
malign
streptococcu
group
g
ie
streptococcu
dysgalactia
subsp
equisimili
haematolog
malign
solid
tumour
former
streptococcu
bovi
group
ie
gallolyticu
subsp
gallolyticu
subsp
pasteurianu
colon
cancer
infantariu
cancer
bile
tree
pancrea
experiment
work
anim
show
increas
risk
bacteri
transloc
subject
fed
exclus
parenter
rout
final
larg
number
condit
link
immunodefici
mucos
barrier
normal
inflammatori
respons
malfunct
signific
microbi
find
eg
singl
detect
speci
signific
pathogen
profil
multipl
detect
lowpathogen
speci
alert
clinician
independ
clinic
sign
sepsi
whether
detect
method
cultur
molecular
combin
method
might
therefor
provid
import
clinic
inform
concern
acut
infect
also
underli
condit
laboratori
usual
take
around
hour
blood
cultur
bottl
flag
posit
isol
grown
enough
plate
enabl
speci
identif
within
minut
malditof
ms
figur
time
primari
read
antibiogram
done
aid
disclos
resist
strain
staphylococcu
aureu
enterobacteriacea
spp
nonferment
howev
time
need
speci
identif
convent
culturebas
method
differ
clinic
laboratori
depend
routin
microarray
turnaround
time
posit
bottl
microorgan
identif
four
hour
includ
prepar
blood
cultur
bottl
dna
extract
estim
use
microarray
would
save
hour
compar
routin
method
labour
intens
blood
cultur
microarray
incub
time
typic
day
must
also
consid
howev
time
save
obtain
use
multiplex
pcr
estim
turnaround
time
seven
hour
sinc
assay
perform
directli
whole
blood
sampl
requir
incub
time
multiplex
pcr
assay
whole
process
control
invalid
partial
invalid
blood
sampl
initi
test
accord
manufactur
whole
process
control
indic
whether
process
function
optim
inform
given
whole
process
control
flag
invalid
specul
high
dna
concentr
sampl
either
inhibit
pcr
reaction
purif
process
therefor
sampl
retest
tenfold
dilut
extract
dna
one
sampl
gave
final
result
high
rate
invalid
whole
process
control
thu
reduc
clinic
util
multiplex
pcr
sinc
sampl
need
retest
studi
sever
limit
one
import
tat
precis
measur
roughli
estim
mainli
due
handl
procedur
addit
none
naat
run
multiplex
pcr
perform
daili
wherea
microarray
ran
everi
second
day
result
indic
use
multiplex
pcr
assay
whole
blood
specimen
may
shorten
time
identifi
caus
agent
blood
microarraybas
assay
correspond
well
blood
cultur
prerequisit
timeconsum
cultiv
reduc
clinic
util
import
found
multiplex
pcr
assay
potenti
serv
complement
blood
cultur
detect
clinic
relev
microb
blood
howev
stress
aetiolog
signific
find
detect
pcrbase
assay
interpret
caution
high
analyt
sensit
may
add
find
necessarili
corrobor
clinic
diagnosi
improv
pcr
technolog
eg
repeat
sampl
increas
diagnost
sensit
process
larger
volum
blood
faster
autom
analysi
make
naat
better
tool
diagnos
septic
patient
